|
Market Closed -
NYSE
16:02:37 2026-09-02 EDT
|
After hours 20:00:00 | |||
| 29.02 USD | +1.65% |
|
28.90 | -0.40% |
| 09-01 | Global pharma companies that have publicly announced Trump drug pricing agreements | RE |
| 09-01 | GSK Moves mRNA Flu Vaccine Candidate to Late-Stage Trial | DJ |
| Market Cap | 165B 143B 134B 122B 229B 15,625B 231B 1,591B 618B 7,989B 621B 608B 26,242B | P/E 2026 * |
18.2x | P/E 2027 * | 14.2x |
|---|---|---|---|---|---|
| Enterprise Value | 213B 184B 173B 158B 295B 20,111B 297B 2,048B 795B 10,282B 799B 782B 33,776B | EV / Sales 2026 * |
3.42x | EV / Sales 2027 * | 3.48x |
| Free-Float |
59.05% | Yield 2026 * |
5.93% | Yield 2027 * | 5.98% |
Last Transcript : Pfizer Inc.
| 1 day | -0.40% | ||
| 1 week | +2.54% | ||
| Current month | +1.97% | ||
| 1 month | +16.03% | ||
| 3 months | +13.58% | ||
| 6 months | +6.46% | ||
| Current year | +16.55% |
| 1 week | 27.64 |  | 29.09 |
| 1 month | 24.7 | | 29.09 |
| Current year | 23.62 | | 29.09 |
| 1 year | 23.58 | | 29.09 |
| 3 years | 20.92 | | 36.29 |
| 5 years | 20.92 | | 61.71 |
| 10 years | 20.92 | | 61.71 |
| Manager | Title | Age | Since |
|---|---|---|---|
Albert Bourla
CEO | Chief Executive Officer | 64 | 2018-12-31 |
Cecile Guegan
DFI | Director of Finance/CFO | 55 | 2026-08-15 |
Rady Johnson
CMP | Compliance Officer | 65 | 2013-11-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Suzanne Johnson
BRD | Director/Board Member | 68 | 2007-08-31 |
Shantanu Narayen
BRD | Director/Board Member | 62 | 2013-09-26 |
Albert Bourla
CHM | Chairman | 64 | 2019-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/17/26 | Other | Chief Financial Officer | 273,464 | 0.0048% | ||
| 8/14/26 | Free | Chief Executive Officer | 22 | 0.0000% | ||
| 8/12/26 | Buy | Chief Executive Officer | 38,000 | 0.0007% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.65% | +2.54% | +16.17% | -18.89% | 163B | |
| +0.01% | -2.47% | +57.79% | +108.23% | 1,034B | |
| +1.48% | +1.93% | +54.56% | +71.49% | 654B | |
| +0.67% | -0.45% | +23.50% | +76.60% | 459B | |
| +0.49% | -5.19% | +33.28% | +34.59% | 343B | |
| +0.27% | +3.26% | +29.76% | +46.97% | 307B | |
| +0.12% | -2.11% | +0.60% | +11.93% | 251B | |
| +1.08% | +0.57% | +54.34% | +72.51% | 237B | |
| +2.64% | -1.08% | -15.85% | -53.64% | 202B | |
| -0.21% | +1.03% | +32.74% | +95.19% | 186B | |
| Average | +0.62% | -1.02% | +28.69% | +44.50% | 383.43B | |
| Weighted average by Cap. | +0.59% | -1.14% | +37.89% | +63.65% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 62.24B 53.69B 50.58B 46.08B 86.14B 5,879B 86.78B 599B 232B 3,006B 234B 229B 9,874B | 59.84B 51.62B 48.63B 44.31B 82.82B 5,653B 83.44B 576B 223B 2,890B 225B 220B 9,494B |
| Net income | 8.9B 7.68B 7.23B 6.59B 12.32B 841B 12.41B 85.63B 33.23B 430B 33.42B 32.69B 1,412B | 11.08B 9.56B 9B 8.2B 15.34B 1,047B 15.45B 107B 41.37B 535B 41.61B 40.7B 1,758B |
| Net Debt | 47.48B 40.96B 38.59B 35.16B 65.72B 4,486B 66.21B 457B 177B 2,293B 178B 174B 7,533B | 42.88B 36.99B 34.85B 31.75B 59.35B 4,051B 59.8B 413B 160B 2,071B 161B 158B 6,803B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-02 | US$29.02 | +1.65% | 39,259,132 |
| 26-09-01 | US$28.55 | +0.32% | 42,493,395 |
| 26-08-31 | US$28.46 | +1.79% | 45,930,349 |
| 26-08-28 | US$27.96 | -0.21% | 27,183,853 |
| 26-08-27 | US$28.02 | -0.99% | 31,174,426 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PFE Stock
Select your edition
All financial news and data tailored to specific country editions
